Literature DB >> 15667969

Prognostic factors of glottic carcinomas treated with radiation therapy: value of the adjacent sign on radiological examinations in the sixth edition of the UICC TNM staging system.

Ryuji Murakami1, Ryuichi Nishimura, Yuji Baba, Mitsuhiro Furusawa, Norihisa Ogata, Eiji Yumoto, Yasuyuki Yamashita.   

Abstract

PURPOSE: To evaluate the predictive value of the adjacent sign, the tumor adjacent to the thyroid cartilage on radiologic examinations, in the new sixth edition of the International Union Against Cancer (UICC) staging system of glottic carcinoma. METHODS AND MATERIALS: Between 1989 and 1998, 130 patients with T1-2N0 glottic squamous cell carcinoma, classified according to the fifth edition of the UICC staging system and evaluated by computed tomography or magnetic resonance imaging, were treated with radiation therapy (RT). Factor analysis included clinical, radiologic, and treatment characteristics. Tumors with the adjacent sign, considered representative of paraglottic space invasion with or without minor thyroid cartilage erosion, were retrospectively classified as T3-stage tumors by the UICC sixth edition.
RESULTS: The 5-year local control rate after RT was 76%. Univariate analysis showed that the T stage according to the UICC fifth edition, supraglottic extension, subglottic extension, tumor size, adjacent sign, total dose, fraction size, field size, and overall treatment time were significant factors for the local control rate. Multivariate analysis confirmed the adjacent sign as the only independent predictor. According to the UICC sixth edition, the 5-year local control, laryngeal preservation, cause-specific survival, and overall survival rates of the T3 (adjacent sign-positive) vs. T1 and T2 (adjacent sign-negative) lesions were 37% vs. 87% (p < 0.0001), 47% vs. 95% (p < 0.0001), 75% vs. 99% (p < 0.0001), and 54% vs. 81% (p = 0.0180), respectively.
CONCLUSION: Factor analysis confirmed the adjacent sign as an independent prognostic factor. The UICC sixth edition appears to identify correctly patients with T3 lesions as a high-risk group.

Entities:  

Mesh:

Year:  2005        PMID: 15667969     DOI: 10.1016/j.ijrobp.2004.05.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Cartilage invasion patterns in laryngeal cancer.

Authors:  Manuel Gómez Serrano; María Cruz Iglesias Moreno; Jesús Gimeno Hernández; Luis Ortega Medina; Cristina Martín Villares; Joaquín Poch Broto
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-23       Impact factor: 2.503

2.  Predictive factors for local control of early glottic squamous cell carcinomas after definitive radiotherapy.

Authors:  Mitsuru Okubo; Tomohiro Itonaga; Tatsuhiko Saito; Sachika Shiraishi; Ryuji Mikami; Akira Sakurada; Shinji Sugahara; Jinho Park; Koichi Tokuuye; Kazuhiro Saito
Journal:  Mol Clin Oncol       Date:  2020-03-30

3.  18F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging.

Authors:  G Paone; F Martucci; V Espeli; L Ceriani; G Treglia; T Ruberto; A Richetti; R Piantanida; L Giovanella
Journal:  Contrast Media Mol Imaging       Date:  2019-09-11       Impact factor: 3.161

Review 4.  Involvement of the Anterior Commissure in Early Glottic Cancer (Tis-T2): A Review of the Literature.

Authors:  Martine Hendriksma; Elisabeth V Sjögren
Journal:  Cancers (Basel)       Date:  2019-08-23       Impact factor: 6.639

5.  [Larynx preservation: recommendations for decision-making in T3 laryngeal cancer patients].

Authors:  Gerhard Dyckhoff; Rolf Warta; Christel Herold-Mende; Peter K Plinkert; Heribert Ramroth
Journal:  HNO       Date:  2022-05-16       Impact factor: 1.330

6.  Survival and Prognostic Factors for Outcome after Radiotherapy for T2 Glottic Carcinoma.

Authors:  Martine Hendriksma; Marc A P van Ruler; Berit M Verbist; Martin A de Jong; Ton P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

7.  Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not?

Authors:  Ryo Toya; Ryuji Murakami; Daizo Murakami; Tetsuo Saito; Tomohiko Matsuyama; Yutaka Toya; Yasuyuki Yamashita; Natsuo Oya
Journal:  Oncotarget       Date:  2017-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.